Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

Gonzalez-Martin, A; Pothuri, B; Vergote, I; Christensen, RD; Graybill, W; Mirza, MR; McCormick, C; Lorusso, D; Hoskins, P; Freyer, G; Baumann, K; Jardon, K; Redondo, A; Moore, RG; Vulsteke, C; O'Cearbhaill, RE; Lund, B; Backes, F; Barretina-Ginesta,

Gonzalez-Martin, A (reprint author), Clin Univ Navarra, Med Oncol Dept, Calle Marquesado de Santa Marta 1, Madrid 28027, Spain.

NEW ENGLAND JOURNAL OF MEDICINE, 2019; 381 (25): 2391

Abstract

BACKGROUND Niraparib, an inhibitor of poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP), has been associated with significantly increased pro......

Full Text Link